POZEN Announces May 8th Webcast of First Quarter 2013 Results
CHAPEL HILL, N.C. -- April 30, 2013
POZEN Inc. (NASDAQ: POZN), a pharmaceutical company committed to transforming
medicine that transforms lives, announced today that it plans to release first
quarter 2013 results on May 8, 2013, before the market opens.
The announcement will be followed by a live webcast at 11:00 a.m. (ET) with a
discussion by POZEN management of the earnings and business results. The
webcast can be accessed on POZEN’s website at www.pozen.com and will be
archived and available for replay. The first quarter 2013 earnings release
will be accessible in the Media section of POZEN’s website.
POZEN Inc. is a small pharmaceutical company that specializes in developing
novel therapeutics for unmet medical needs and licensing those products to
other pharmaceutical companies for commercialization. By utilizing a unique
in-source model and focusing on integrated therapies, POZEN has successfully
developed and obtained FDA approval of two self-invented products in two
years. Funded by these milestones/royalty streams, POZEN is creating a
portfolio of cost-effective, evidence-based integrated aspirin therapies
designed to enable the full power of aspirin by reducing its GI damage.
POZEN is currently seeking strategic partners to help maximize the
opportunities for its portfolio assets.
The Company's common stock is traded under the symbol “POZN” on The NASDAQ
Global Market. For more detailed company information, including copies of this
and other press releases, please visit www.pozen.com.
Bill Hodges, 919-913-1030
Chief Financial Officer
Stephanie Bonestell, 919-913-1030
Manager, Investor Relations & Public Relations
Press spacebar to pause and continue. Press esc to stop.